ArticleTargeted oncologyPublished
Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics
Regional connection
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Article
- Venue
- Targeted oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Antibodies, Bispecific; Cytokines; Retrospective Studies; Female; Male; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic
- PubMed ID
- 41886220
- PubMed Central ID
- PMC13222323
- Open access
- Yes, open
- Added to directory
- Source checked